09 April 2024

Highlights from Day 4 at EAU24

Below are some highlights from the last day of EAU24, including session reports, a webcast, and a new episode of

08 April 2024

Urothelial cancer: Practice-changing results

Why is there no added benefit to extended pelvic lymph node dissection (ePLND)? The Plenary Session on day 4 of

08 April 2024

Male LUTS session dispels myths, explores causes and genetic link

Plenary Session “Male LUTS: Prevention, attention, intervention” led by Chairs Prof. Jean-Nicolas Cornu (FR) and Prof. Christian Gratzke (DE) explored

08 April 2024

EAUTV: Male LUTS at EAU24

08 April 2024

Expert discussion: Best of EAU24 Abstracts

Primarily as a showcase for the best new research presented over the last few days, but certainly also in part

08 April 2024

Highlights from Day 3 at EAU24

Day 3 of EAU24 continues to deliver! You can catch up on some of the highlights from the day in

07 April 2024

EAUTV: Advanced Prostate Cancer at EAU24

07 April 2024

Treating rUTIs: Immunomodulation or oestrogen therapy?

In the Thematic Session “Controversies on EAU Guidelines: Neurourology, paediatric urology and infections”, Co-Chair Prof. Gernot Bonkat (CH) presented and

07 April 2024

EAUTV: Prostate Cancer Screening at EAU24

07 April 2024

EAUTV: Surgical Complications at EAU24

07 April 2024

The one about the urologist who never has complications

ESU Chair Prof. Liatsikos (GR) has met the urologist who never has complications: “He comes in at 9:30, gets a

07 April 2024

PCa Game changers: Limited versus extended PLND?

On day three of EAU24, the newest data comparing limited versus extended pelvic lymph node dissection (ePLND) in prostate cancer

07 April 2024

Highlights from Day 2 at EAU24

See the highlights of EAU24’s day 2, including session reports on prostate cancer screening and live surgeries, PRIME and PROBASE